PMID- 35996020
OWN - NLM
STAT- MEDLINE
DCOM- 20221104
LR  - 20221106
IS  - 1476-5365 (Electronic)
IS  - 0268-3369 (Linking)
VI  - 57
IP  - 11
DP  - 2022 Nov
TI  - Donor lymphocyte infusion (DLI) post haploidentical stem cell transplantation 
      (Haplo) with post-transplant cyclophosphamide (PTCy): crossing the human 
      leukocyte antigen (HLA) barrier.
PG  - 1640-1641
LID - 10.1038/s41409-022-01785-5 [doi]
FAU - Nagler, Arnon
AU  - Nagler A
AUID- ORCID: 0000-0002-0763-1265
AD  - Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv 
      University, Tel Aviv-Yafo, Israel.
FAU - Tsirigotis, Panagiotis
AU  - Tsirigotis P
AUID- ORCID: 0000-0002-3522-3680
AD  - Second Department of Internal Medicine, ATTIKO General University Hospital, 
      National and Kapodistrian University of Athens, 12462, Athens, Greece. 
      panagtsirigotis@gmail.com.
LA  - eng
PT  - Journal Article
DEP - 20220822
PL  - England
TA  - Bone Marrow Transplant
JT  - Bone marrow transplantation
JID - 8702459
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - 0 (HLA Antigens)
SB  - IM
MH  - Humans
MH  - *Hematopoietic Stem Cell Transplantation
MH  - Cyclophosphamide/pharmacology/therapeutic use
MH  - HLA Antigens
MH  - Lymphocytes
MH  - *Graft vs Host Disease
MH  - Transplantation Conditioning
MH  - Retrospective Studies
EDAT- 2022/08/23 06:00
MHDA- 2022/11/05 06:00
CRDT- 2022/08/22 23:31
PHST- 2022/04/22 00:00 [received]
PHST- 2022/08/08 00:00 [accepted]
PHST- 2022/07/24 00:00 [revised]
PHST- 2022/08/23 06:00 [pubmed]
PHST- 2022/11/05 06:00 [medline]
PHST- 2022/08/22 23:31 [entrez]
AID - 10.1038/s41409-022-01785-5 [pii]
AID - 10.1038/s41409-022-01785-5 [doi]
PST - ppublish
SO  - Bone Marrow Transplant. 2022 Nov;57(11):1640-1641. doi: 
      10.1038/s41409-022-01785-5. Epub 2022 Aug 22.